Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Caron

Showing results (111-120 of 232) with videos related to

Pageof 24
Sort By:
Neuropharmacology|February 8, 2011
Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout miceWarren H Meck, Ruey-Kuang Cheng, Christopher J MacDonald, et al.
Neuroscience Letters|September 24, 2013
Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function miceChristinna V Jørgensen, Jacob P Jacobsen, Marc G Caron, et al.
Science (New York, N.Y.)|December 25, 2004
Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathwayAlyson M Wilbanks, Gregory B Fralish, Margaret L Kirby, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 7, 2007
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activityNiels H Jensen, Ramona M Rodriguiz, Marc G Caron, et al.
Circulation|September 1, 2004
Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activityNancy R Keller, André Diedrich, Martin Appalsamy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Vmat2 heterozygous mutant mice display a depressive-like phenotypeMasato Fukui, Ramona M Rodriguiz, Jiechun Zhou, et al.
Plos One|April 22, 2009
Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleepKafui Dzirasa, Lucas M Santos, Sidarta Ribeiro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 2006
Effect of antidepressant drugs in mice lacking the norepinephrine transporterMarta Dziedzicka-Wasylewska, Agata Faron-Górecka, Maciej Kuśmider, et al.
The Journal of Biological Chemistry|September 28, 2014
G Protein and β-arrestin signaling bias at the ghrelin receptorTama Evron, Sean M Peterson, Nikhil M Urs, et al.
Psychopharmacology|January 30, 2004
MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout miceSusan B Powell, Virginia D Lehmann-Masten, Martin P Paulus, et al.
Pageof 24

Showing results (111-120 of 232) with videos related to

Sort By:
Pageof 24
Neuropharmacology|February 8, 2011
Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout miceWarren H Meck, Ruey-Kuang Cheng, Christopher J MacDonald, et al.
Neuroscience Letters|September 24, 2013
Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function miceChristinna V Jørgensen, Jacob P Jacobsen, Marc G Caron, et al.
Science (New York, N.Y.)|December 25, 2004
Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathwayAlyson M Wilbanks, Gregory B Fralish, Margaret L Kirby, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 7, 2007
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activityNiels H Jensen, Ramona M Rodriguiz, Marc G Caron, et al.
Circulation|September 1, 2004
Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activityNancy R Keller, André Diedrich, Martin Appalsamy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Vmat2 heterozygous mutant mice display a depressive-like phenotypeMasato Fukui, Ramona M Rodriguiz, Jiechun Zhou, et al.
Plos One|April 22, 2009
Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleepKafui Dzirasa, Lucas M Santos, Sidarta Ribeiro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 2006
Effect of antidepressant drugs in mice lacking the norepinephrine transporterMarta Dziedzicka-Wasylewska, Agata Faron-Górecka, Maciej Kuśmider, et al.
The Journal of Biological Chemistry|September 28, 2014
G Protein and β-arrestin signaling bias at the ghrelin receptorTama Evron, Sean M Peterson, Nikhil M Urs, et al.
Psychopharmacology|January 30, 2004
MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout miceSusan B Powell, Virginia D Lehmann-Masten, Martin P Paulus, et al.
Pageof 24